Board ChangesMarch 19, 2018
As of 1st April and following an internal restructure as the business continues to grow, Tissuemed is pleased to announce two new additions to its Board of Directors. Peter Maver (Head of Sales for over two years) becomes Managing Director and Dr Ian Thompson (Chief Technical Officer for many years) becomes Operations Director. These appointments coincide with the departure of Dr David Mandley, CEO for the past six years.
Chairman Paul Banner said; ‘having been CEO for over 6 years David has presided over the business in a period that has seen unprecedented change for the better. He leaves us with our best wishes, and the company in a very solid place from which to grow. We’re very excited to announce Peter and Ian’s appointments – they were natural additions that strengthen the Board following on from David’s departure. Both Peter and Ian know our business inside out and as we continue to transition into a more sales-led business are both fully focused on the task ahead.’